MCM
MRNA icon

Militia Capital Management’s Moderna MRNA Stock Holding History

Militia Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
+148,500
New +$7.68M 0.31% 21

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Militia Capital Management's MRNA Position: Q2 2026 in Review

Militia Capital Management increased its Moderna (MRNA) stake by 373% in Q2 2026, buying an estimated $4.43M and bringing the position to 108,701 shares worth $7.61M. The position accounts for 0.23% of the portfolio, ranked #30.

Militia Capital Management first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 730 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Militia Capital Management held 108,701 shares of Moderna worth $7.61M as of Q2 2026.
  • Militia Capital Management bought 85,700 Moderna shares in Q2 2026, an estimated $4.43M.
  • Moderna made up 0.23% of Militia Capital Management's portfolio in Q2 2026, its #30 holding.
  • Militia Capital Management first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 730 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Militia Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.